Comparing platelet transfusion volumes in premature babies
Part of Blood & lymphatic clinical trials.
This study compares two different amounts of platelet transfusions to see which is safer and more effective for premature babies with very low platelet counts. Platelets are tiny cells in the blood that help stop bleeding, so this treatment may reduce the risk of serious bleeding in the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born at 32 weeks of pregnancy or earlier, or weighed less than 1500 grams at birth.
- Your baby has a very low platelet count (below 25 x 10^9 per liter), which is a type of severe thrombocytopenia.
- Your baby is admitted to a participating neonatal intensive care unit (NICU), including if they were transferred there after birth.
- An ultrasound of your baby's brain within the last 24 hours shows no recent major bleeding in the brain.
- Your baby does not have major birth defects or certain genetic conditions.
- Your baby is not on palliative care and has not had a major bleed in the last 72 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the best way to decide when to give platelet transfusions to very premature babies. It aims to help prevent bleeding while avoiding unnecessary transfusions.
This study looks at how giving platelets to patients with low platelet counts affects the health of small blood vessels. It aims to see if platelet transfusions help improve blood flow and vessel function in critically ill patients.
This study tests a machine called ROTEM Sigma that measures how well your blood clots, specifically in pregnant women who have or may have low platelet counts (cells that help blood clot). The goal is to help doctors better predict bleeding problems during or after delivery.
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
This trial looks at how to estimate bleeding risk in newborns who are very premature and have a low platelet count. The goal is to guide safer care by better identifying which babies may be at higher risk of bleeding.
This study tests whether giving platelet transfusions to critically ill patients with very low platelet counts helps prevent dangerous bleeding. If you're in the ICU with a very low platelet count, this trial might help decide the best way to keep you safe.
Hear when a new Thrombocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.